385 related articles for article (PubMed ID: 31101329)
1. [Treatment of ITP and AIHA in CVID: A systematic literature review].
Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
[TBL] [Abstract][Full Text] [Related]
2. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID).
Wang J; Cunningham-Rundles C
J Autoimmun; 2005 Aug; 25(1):57-62. PubMed ID: 15994061
[TBL] [Abstract][Full Text] [Related]
3. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.
Ramyar A; Aghamohammadi A; Moazzami K; Rezaei N; Yeganeh M; Cheraghi T; Pouladi N; Heydari G; Abolhassani H; Amirzargar AA; Parvaneh N; Moin M
Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):169-75. PubMed ID: 18780952
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent infections in an ITP patient treated with rituximab].
Rosenberg-Bezalel S; Asher I; Sthoeger Z
Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
[TBL] [Abstract][Full Text] [Related]
5. [Primary immunodeficiencies presenting with autoimmune cytopenias in adults].
Sève P; Broussolle C; Pavic M
Rev Med Interne; 2013 Mar; 34(3):148-53. PubMed ID: 22703729
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging treatments for immune thrombocytopenia.
Dou X; Yang R
Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
[No Abstract] [Full Text] [Related]
7. ITP and international guidelines: what do we know, what do we need?
Rodeghiero F; Ruggeri M
Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
9. Current treatment strategies in autoimmune hemolytic disorders.
Barcellini W
Expert Rev Hematol; 2015 Oct; 8(5):681-91. PubMed ID: 26343892
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
11. [Secondary ITP in adults].
Michel M; Lega JC; Terriou L
Rev Med Interne; 2021 Jan; 42(1):50-57. PubMed ID: 33139079
[TBL] [Abstract][Full Text] [Related]
12. Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency.
Pedini V; Savore I; Danieli MG
Isr Med Assoc J; 2017 Jul; 19(7):420-423. PubMed ID: 28786256
[TBL] [Abstract][Full Text] [Related]
13. [Current treatment of primary immune thrombocytopenia].
Lozano ML; Vicente V
Med Clin (Barc); 2014 May; 142(9):399-405. PubMed ID: 23809409
[TBL] [Abstract][Full Text] [Related]
14. Treatment of autoimmune hemolytic anemias.
Zanella A; Barcellini W
Haematologica; 2014 Oct; 99(10):1547-54. PubMed ID: 25271314
[TBL] [Abstract][Full Text] [Related]
15. Management of immune thrombocytopenia in elderly patients.
Lucchini E; Fanin R; Cooper N; Zaja F
Eur J Intern Med; 2018 Dec; 58():70-76. PubMed ID: 30274902
[TBL] [Abstract][Full Text] [Related]
16. [New treatment methods for autoimmune thrombocytopenia].
Koene HR
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2609-14. PubMed ID: 18161261
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of primary immune thrombocytopenia in adults.
Ejaz A; Radia D
Br J Hosp Med (Lond); 2019 Apr; 80(4):C54-C57. PubMed ID: 30951423
[No Abstract] [Full Text] [Related]
18. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
Diehl LF; Ketchum LH
Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
[TBL] [Abstract][Full Text] [Related]
19. A de novo monoallelic CTLA-4 deletion causing pediatric onset CVID with recurrent autoimmune cytopenias and severe enteropathy.
Lougaris V; Baronio M; Gazzurelli L; Lorenzini T; Fuoti M; Moratto D; Bozzola A; Ricci C; Bondioni MP; Ravelli A; Villanacci V; Plebani A
Clin Immunol; 2018 Dec; 197():186-188. PubMed ID: 30326257
[No Abstract] [Full Text] [Related]
20. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
